Therapeutic Potential of a Novel α(v)β(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type

The mesenchymal sub-type of triple negative breast cancer (MES-TNBC) has a highly aggressive behavior and worse prognosis, due to its invasive and stem-like features, that correlate with metastatic dissemination and resistance to therapies. Furthermore, MES-TNBC is characterized by the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Billy Samuel, Sarnella, Annachiara, Capasso, Domenica, Comegna, Daniela, Del Gatto, Annarita, Gramanzini, Matteo, Albanese, Sandra, Saviano, Michele, Zaccaro, Laura, Zannetti, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406933/
https://www.ncbi.nlm.nih.gov/pubmed/30682838
http://dx.doi.org/10.3390/cancers11020139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406933/
https://www.ncbi.nlm.nih.gov/pubmed/30682838
http://dx.doi.org/10.3390/cancers11020139

Ejemplares similares